A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid
- PMID: 1302033
- DOI: 10.1038/ng0892-345
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid
Abstract
Mutations at codon 717 in exon 17 of the beta-amyloid precursor protein (APP) gene have previously been shown to segregate with early onset Alzheimer's disease in some families. We have identified a double mutation at codons 670 and 671 (APP 770 transcript) in exon 16 which co-segregates with the disease in two large (probably related) early-onset Alzheimer's disease families from Sweden. Two base pair transversions (G to T, A to C) from the normal sequence predict Lys to Asn and Met to Leu amino acid substitutions at codons 670 and 671 of the APP transcript. This mutation occurs at the amino terminal of beta-amyloid and may be pathogenic because it occurs at or close to the endosomal/lysosomal cleavage site of the molecule. Thus, pathogenic mutations in APP frame the beta-amyloid sequence.
Similar articles
-
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.Nature. 1991 Oct 31;353(6347):844-6. doi: 10.1038/353844a0. Nature. 1991. PMID: 1944558
-
Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease.Ann Neurol. 1994 Apr;35(4):432-8. doi: 10.1002/ana.410350410. Ann Neurol. 1994. PMID: 8154870
-
Mutation in codon 713 of the beta amyloid precursor protein gene presenting with schizophrenia.Nat Genet. 1992 Jul;1(4):306-9. doi: 10.1038/ng0792-306. Nat Genet. 1992. PMID: 1307241
-
[Mutation analysis of amyloid precursor protein in early-onset familial Alzheimer's disease].Nihon Rinsho. 1993 Sep;51(9):2445-51. Nihon Rinsho. 1993. PMID: 8411726 Review. Japanese.
-
The amyloid peptide precursor in Alzheimer's disease.Acta Neurol Belg. 1995 Dec;95(4):197-209. Acta Neurol Belg. 1995. PMID: 8553793 Review.
Cited by
-
Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation.Mol Neurodegener. 2013 Jan 14;8:2. doi: 10.1186/1750-1326-8-2. Mol Neurodegener. 2013. PMID: 23316765 Free PMC article.
-
Genetic animal models of cerebral vasculopathies.Prog Mol Biol Transl Sci. 2012;105:25-55. doi: 10.1016/B978-0-12-394596-9.00002-0. Prog Mol Biol Transl Sci. 2012. PMID: 22137428 Free PMC article. Review.
-
Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease.J Neuropathol Exp Neurol. 2012 Jan;71(1):2-14. doi: 10.1097/NEN.0b013e31823cc7a6. J Neuropathol Exp Neurol. 2012. PMID: 22157615 Free PMC article.
-
The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.J Neurosci. 2003 Mar 15;23(6):2086-92. doi: 10.1523/JNEUROSCI.23-06-02086.2003. J Neurosci. 2003. PMID: 12657667 Free PMC article.
-
A unique gene expression signature discriminates familial Alzheimer's disease mutation carriers from their wild-type siblings.Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14854-9. doi: 10.1073/pnas.0504178102. Epub 2005 Sep 30. Proc Natl Acad Sci U S A. 2005. PMID: 16199521 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous